A new University of British Columbia study reveals that mild breast symptoms before menstruation are more common in cycles with normal ovulation than in disturbed ones.

GSK and Spero Therapeutics announced that the phase 3 PIVOT-PO trial for tebipenem HBr, a potential first oral carbapenem for cUTIs in the United States, was stopped early because of positive efficacy results.

A new study shows that a self-collected cervical cancer screening device is highly accurate, easy to use, and preferred over clinician collection.

RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule.

Women living in neighborhoods with very high social vulnerability are more likely to experience natural menopause at a younger age, according to new research.

A new study finds that a daily 150 mg dose of aspirin significantly improves thromboxane B2 inhibition compared to 75 mg in pregnant women at risk for preeclampsia.

A new study highlights how dismissive medical experiences, including gaslighting, contribute to emotional distress and care avoidance among patients with vulvovaginal disorders.

A thoughtful approach to behavioral change.

In this Q&A, Karyn S. Eilber, MD, shares some of the biggest takeaways from the new AUA/SUFU/AUGS 2025 Guidelines on Genitourinary Syndrome of Menopause.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study finds that Texas' restrictive abortion law significantly increased rates of mental distress among reproductive-aged women, especially those aged 18 to 29 years.

Angie Lee, MD, FACOG, discusses how clinicians can bridge the gap in menopause care to ensure better outcomes for their patients.

A study found that biologic treatment rates decline during pregnancy and only partially rebound postpartum, with trends varying by autoimmune condition.

Find out what you may have missed at the 2025 ACOG ACSM.

Watch some highlights from our discussions with experts presenting at the 2025 ACOG meeting.

A study found the greatest reduction in neonatal mortality occurs when antenatal corticosteroids are given 24 hours to 14 days before preterm delivery.

A structured surgical approach, imaging tools, and careful platform choice support optimal endometriosis management, according to Trina Mansour, MD, at the 2025 ACOG ACSM.

Tia Welsh, MD, MPH, FACOG, shares new evidence showing that single-use negative pressure wound therapy at -80 mmHg lowers cesarean-section infection rates and healthcare costs more effectively than traditional -125 mmHg therapy.

Amy Valent, DO, MCR, discusses how continuous glucose monitors and smart insulin delivery tools are reshaping individualized care for pregnant patients with diabetes.

Lisa Bayer, MD, MPH, details her presentation at the 2025 ACOG ACSM pain management during IUD placement.

Megan Wasson, DO, discusses surgical precision, imaging, and mentorship to improve endometriosis care at the 2025 ACOG Annual Meeting.

Research presented at the 2025 ACOG ACSM highlighted the potential risks tied to personal care product use among African American pregnant patients.

In an abstract featured at the 2025 ACOG ACSM, researchers found that after Dobbs, North Carolina saw more out-of-state abortion patients, longer wait times, and increased racial disparities.

A comparison of 4 ultrasound-based algorithms demonstrated strong performance, with nuanced implications for clinical practice, according to a new study presented at the 2025 ACOG ACSM.

Megan Cohen, MD, MPH, outlines major changes to the CDC’s 2024 contraceptive recommendations, including updated safety classifications, inclusive language, and new guidance for transgender and medically complex patients.